North America is the leader in drug integrated polymer fiber market followed by the Europe owing to developed medical and healthcare industry in these regions.

Sellbyville, DE -- (SBWire) -- 05/06/2019 --Global Market Insights recently introduced new report on global Drug Integrated Polymer Fibers market with an in-depth study providing complete analysis of the industry size, share and statistics for the period 2019 to 2025. It also provides complete overview of Drug Integrated Polymer Fibers industry considering all the major industry trends, market dynamics and competitive scenario.

North America is the leader in drug integrated polymer fiber market followed by the Europe owing to developed medical and healthcare industry in these regions. However, the increasing investment in healthcare facilities and rapidly developing population in emerging economies such as China and India are expected to witness a significant growth in drug integrated polymer fibers market in near future.

Request for a sample copy of this report @
https://www.gminsights.com/request-sample/detail/3103

Increasing population, high investment in healthcare facilities by government and private organizations, technological development in medical textile engineering, growing implantable and organ transplantation surgeries, innovations in biomaterials owing to increased R&D activities, are expected to drive the drug integrated polymer fibers market by 2025. The market will exceed USD 88.0 million by 2025; according to a new research report.

Drug integrated polymer fibers are available in custom size and shape for use in several biomedical applications which need polymers to meet special biological requirements. These fibers are manufactured using different processes. The targeted use of the drug integrated polymer fiber plays an important role in the determination of method to be used for the manufacturing of these fibers. On commercial scale these fibers are generally manufactured by using melt extrusion method which utilizes high temperature conditions and high shear stress which negatively affects the biologics and pharmaceuticals. In order to address the limitations of melt extrusion method, a wet extrusion method which require comparatively lower temperature and lower shear stress, has been developed for the manufacturing of drug integrated polymer fibers.

Developments in fiber based wound healing systems, biologics, pharmaceutical products along with significant growth in tissue engineering and regenerative medicine are driving the orthopedic medical products market which is expected to witness a rapid growth in drug integrated polymer fiber market during the forecast period.

Drug Integrated Polymer Fibers market research report includes in-depth coverage of the industry, with estimates & forecast in terms of volume in tons and revenue in USD million from 2014 to 2025, for the following segments:

Drug integrated polymer fibers market by type
o Polylactic acid
o Polydioxanone
o Polycaprolactone
o Others (PGA, PLGA, PDLL)

Drug integrated polymer fibers market by application
- Drug delivery
- Orthopaedic sutures
- Vascular stents
- Vascular grafts
- Dermal wound healing

Make an Inquiry for Purchasing this Report @
https://www.gminsights.com/inquiry-before-buying/3103

Drug integrated polymer fibers are also called as pharmaceutical fibers and are generally made up of biocompatible and biodegradable materials such as polylactic acid and its different derivatives like polydioxanone, polyglycolic acid, polycaprolactone, poly (lactic-co-glycolic acid), PLLA and other copolymers. For medical textile device these fibers are generally available in braided, knitted and woven form. Drug integrated polymer fibers are extensively used in drug delivery, orthopaedics, healing of skin wound, vascular grafts, etc. Increase in research and development for innovative materials used in orthopedics and wound healing is expected to boost the market owing to increase in old age population across world.

Drug integrated polymer fibers are extensively used in several biomedical applications such as orthopaedic sutures, drug delivery, vascular grafts, vascular stents, dermal wound healing, etc. owing to their biocompatible and biodegradable properties. Biomedical textile applications of these fibers are mainly targeted for soft tissue replacement and soft tissue engineering such as cartilage, retina, blood, cardiac muscle, nerve, etc. owing to flexible and fibrous nature of these fibers.

The Drug Integrated Polymer Fibers Market report offers detailed competitive landscape of the global market. It includes companies, industry statistics, market share analysis and product portfolio of the major industry participants. The report provides detailed segmentation of the Drug Integrated Polymer Fibers market based on product, technology, end user and region.

Browse Report Summery @
https://www.gminsights.com/industry-analysis/drug-integrated-polymer-fibers-market

Currently, only Micro Engineering Solutions and TissueGen Inc, are the two key players in this business. However, in future many companies are expected to enter in drug integrated polymer fibers market owing to biodegradable and biocompatible nature and hidden potential of these fibers for biomedical applications such as drug delivery, dermal wound healing, orthopaedic sutures, vascular grafts, etc.

About Global Market Insights:
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.